Applied Therapeutics (APLT)
(Delayed Data from NSDQ)
$7.68 USD
-0.02 (-0.26%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $7.67 -0.01 (-0.13%) 6:36 PM ET
2-Buy of 5 2
F Value C Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
APLT 7.68 -0.02(-0.26%)
Will APLT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for APLT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APLT
All You Need to Know About Applied Therapeutics (APLT) Rating Upgrade to Buy
APLT Stock Soars 69% on Positive Update on Galactosemia Drug NDA
APLT: What are Zacks experts saying now?
Zacks Private Portfolio Services
G1 Therapeutics (GTHX) Reports Q1 Loss, Lags Revenue Estimates
Applied Therapeutics (APLT) Surges 124% in a Month: Here's Why
Bears are Losing Control Over Applied Therapeutics Inc. (APLT), Here's Why It's a 'Buy' Now
Other News for APLT
Biotech Alert: Searches spiking for these stocks today
Applied Therapeutics: AdCom Decision Takes Govorestat Approval A Step Closer
Citi ups Applied Therapeutics target, opens 'positive catalyst watch'
APLT Soars After FDA Scraps Advisory Committee Meeting
Eyes on Fed ahead of expected interest rate cut: Morning Buzz